最新消息
獲取50%折扣優惠 0
🧮 還在用落伍方式,慢慢選股?試試新方法,體驗AI選股魔力解鎖數據
關閉

PGIM Jennison Health Sciences Fund- Class Z(PHSZX)

建立提醒
新的!
建立提醒
網站
  • 作為提醒通知
  • 您要登陸到您的賬戶才能使用此功能
移動應用程序
  • 您要登陸到您的賬戶才能使用此功能
  • 請確保您使用相同的用戶資料登入

條件

頻率

一次
%

頻率

頻率

傳達方式

狀態

從投資組合中新增/移除 新增至觀察名單
加入觀察名單
新增持倉盤

頭寸被成功添加到:

請為您的持倉投資組合命名
 
49.57 -0.12    -0.24%
18/06 - 延遲資料. USD 貨幣 ( 免責聲明 )
種類:  基金
市場:  美國
發行者:  Prudential Funds (PGIM Investments)
資產類別:  股票
  • 晨星評級:
  • 總資產: 929.16M
Prudential Jennison Health Sciences Z 49.57 -0.12 -0.24%

PHSZX綜觀

 
你可在本頁找到深入的PGIM Jennison Health Sciences Fund- Class Z公司檔案,包括PHSZX的主要管理層、總資產、投資策略及聯絡資料,以及各類其他資訊。
類別

Health

總資產

929.16M

費用

0.86%

基金成立

36341

聯絡資訊

地址 One Seaport Plaza
New York,NY 10292
United States
電話 +1 8002251852

主要管理層

名稱 主旨 成立於 直至
Daniel Matviyenko Managing Director 2020 now
自傳 Dan Matviyenko is a portfolio manager for Jennison’s healthcare strategies. He is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2020, Dan was with Malleus Capital as founder, chief investment officer, and portfolio manager. Prior to that, he held various senior positions at Tudor Investment as partner and portfolio manager as well as at UBS O’Connor as an executive director and portfolio manager. Dan received a BS in finance from the University of Connecticut.
Debra Netschert Managing Director 2015 now
自傳 Debra Netschert is a portfolio manager for Jennison’s healthcare strategies. She is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2008, she was with Magnetar Capital as a senior analyst specializing in health care. Prior to that, she worked at Amaranth Advisors focusing on biopharmaceuticals and at Lazard Capital Markets covering biotechnology. Debra began her research career as an associate biotechnology analyst at UBS. She received a BS in health science and MS in physical therapy from Boston University.
David Chan Portfolio Manager 1999 2022
自傳 David Chan, CFA, is a Managing Director and a Health Sciences Equity Portfolio Manager and Research Analyst of Jennison. Mr. Chan joined Jennison Associates in May 1992. He was previously with the Boston Consulting Group, where he was a team leader and consultant on projects in a wide variety of industries, but with a special focus in the health care area. Mr. Chan has also worked in various positions in the film and television industry. He received a BA in biochemistry from Harvard University and an MBA from Columbia University.
Michael A. Del Balso Director 2000 2017
自傳 Michael Del Balso is a large cap growth portfolio manager. He joined Jennison in 1972 as a research analyst. He later served as the director of research and became a portfolio manager in 1999. Prior to Jennison, he was a portfolio manager and research analyst at White, Weld & Company. Michael received a BS in industrial administration from Yale University and an MBA from Columbia University Business School.
John Van Belle Managing Director 1999 2002
自傳 John Van Belle, PhD, is a Managing Director and Portfolio Manager for QMA working within the Quantitative Equity team. In this capacity, he manages global and non-US portfolios. Prior to joining QMA, John taught Economics and Finance at the University of Virginia and Rutgers Graduate School of Management and was a Vice President in Currency Management Consulting at both Bankers Trust and Citibank. Previously, he worked in the Research department of the Federal Reserve Bank of New York. He has published numerous articles in the fields of Economics and Finance. John earned a BS in Economics from St. Joseph's College and a PhD in Economics from the University of Virginia.
Kathleen A. McCarragher Managing Director 1999 2000
自傳 Kathleen McCarragher is the head of growth equity and a large cap growth equity portfolio manager. She is responsible for overseeing the investment process, strategy implementation, and risk management for Jennison's growth equity platform. Kathleen is also a member of the Jennison Management Team, ESG Investment Leadership Team, and Jennison Board of Directors. Before joining Jennison in 1998, she was a managing director and the director of large cap growth equities with Weiss, Peck & Greer. Prior to that, she was an investor with State Street Research & Management. Kathleen received a BBA, summa cum laude, in finance and economics from the University of Wisconsin-Eau Claire and an MBA from Harvard Business School.
評論守則
我们鼓励您使用评论,与用户沟通,共享您的观点并向作者及互相提问。 但是,为了获得有价值和期待的高水平评论,请注意以下标准:
  • 丰富对话
  • 保持关注及正确方向。 只发布与所讨论话题相关的材料。
  • 保持尊重。 即使是负面的意见,也可以用积极的外交辞令进行组织。
  • 用标准书写风格。 包括标点和大小写。
  • 注: 评论中如有垃圾和/或促销信息和链接都将被删除。
  • 避免亵渎、诽谤或人身攻击,对于作者或其他用户。
  • 仅允许中文评论。

垃圾邮件或滥发信息的肇事者都将被从网站删除并禁止以后进行注册,这由Investing.com自由决定。

PHSZX評論

寫下您對PGIM Jennison Health Sciences Fund- Class Z的看法
 
確定要刪除這個圖表?
 
留言
也張貼至:
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
感謝您的評論。請註意,所有的評論都需要我們版主的批準。因此,可能過一些時間您的評論才會出現在我們的網站上。
 
確定要刪除這個圖表?
 
留言
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
在留言中加插圖表
確認封鎖

你確定要封鎖 %USER_NAME%?

此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。

%USER_NAME% 已成功加入你的封鎖清單

你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。

舉報此評論

我覺得這個評論是:

評論被加標記

謝謝!

您的報告已被發送到我們的版主審核
以 Google 登入
以電子郵件註冊